Skip to Content

Bismuth Subsalicylate/Metronidazole/Tetracycline (Helidac Therapy)

Last Updated: April 25, 2014
Status: Discontinued

Products Affected - Description

Helidac Therapy, Prometheus Laboratories
Three drug kit, 56 count (NDC 65483-0495-14)

Reason for the Shortage

  • Prometheus Laboratories discontinued Helidac Therapy due to business decisions and the global shortage of tetracycline.
  • Aptalis has available Pylera capsules (NDC 58914-0601-20) and this product is not affected by the shortage.

Available Products

No presentations are available.

Estimated Resupply Dates

Prometheus Laboratories discontinued Helidac Therapy in 2014.

Related Shortages


April 25, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.